The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finn, P. W.
Right arrow Articles by Perkins, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finn, P. W.
Right arrow Articles by Perkins, D. L.
The Journal of Immunology, 2001, 167: 5994-6001.
Copyright © 2001 by The American Association of Immunologists

Inhibition of NF-{kappa}B-Dependent T Cell Activation Abrogates Acute Allograft Rejection1

Patricia W. Finn*,{dagger}, James R. Stone{ddagger}, Mark R. Boothby§ and David L. Perkins2,*

* Laboratory of Molecular Immunology, {dagger} Pulmonary and Critical Care, Department of Medicine, and {ddagger} Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; and § Department of Medicine, Vanderbilt University, Nashville, TN 37232

Using a heterotopic model of transplantation, we investigated the role of T cell activation in vivo during allograft rejection in I-{kappa}B({Delta}N)-transgenic mice that express a transdominant inhibitor of NF-{kappa}B in T cells. Our results show indefinite prolongation of graft survival in the I-{kappa}B({Delta}N)-transgenic recipients. Interestingly, at the time of rejection of grafts in wild-type recipients, histology of grafts in the I-{kappa}B({Delta}N)-transgenic recipients showed moderate rejection; nevertheless, grafts in the I-{kappa}B({Delta}N) recipients survived >100 days. Analysis of acute phase cytokines, chemokine, chemokine receptors, and immune responses shows that the blockade of NF-{kappa}B activation in T cells inhibits up-regulation of many of these parameters. Interestingly, our data also suggest that the T cell component of the immune response exerted positive feedback regulation on the expression of multiple chemokines that are produced predominantly by non-T cells. In conclusion, our studies indicate NF-{kappa}B activation in T cells is necessary for acute allograft rejection.




This article has been cited by other articles:


Home page
BloodHome page
J. Koreth, K. E. Stevenson, H. T. Kim, M. Garcia, V. T. Ho, P. Armand, C. Cutler, J. Ritz, J. H. Antin, R. J. Soiffer, et al.
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
Blood, October 29, 2009; 114(18): 3956 - 3959.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Bunting, S. Rao, K. Hardy, D. Woltring, G. S. Denyer, J. Wang, S. Gerondakis, and M. F. Shannon
Genome-Wide Analysis of Gene Expression in T Cells to Identify Targets of the NF-{kappa}B Transcription Factor c-Rel
J. Immunol., June 1, 2007; 178(11): 7097 - 7109.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Minamoto, H. Harada, V. N. Lama, M. A. Fedarau, and D. J. Pinsky
Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase
J. Exp. Med., July 18, 2005; 202(2): 283 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Zhou, S. J. Balin, M. Mashayekhi, K. W. Hwang, D. A. Palucki, and M.-L. Alegre
Transplantation Tolerance in NF-{kappa}B-Impaired Mice Is Not Due to Regulation but Is Prevented by Transgenic Expression of Bcl-xL
J. Immunol., March 15, 2005; 174(6): 3447 - 3453.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. El-Sawy, M. Miura, and R. Fairchild
Early T Cell Response to Allografts Occuring Prior to Alloantigen Priming Up-Regulates Innate-Mediated Inflammation and Graft Necrosis
Am. J. Pathol., July 1, 2004; 165(1): 147 - 157.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Sun, L. A. Welniak, A. Panoskaltsis-Mortari, M. J. O'Shaughnessy, H. Liu, I. Barao, W. Riordan, R. Sitcheran, C. Wysocki, J. S. Serody, et al.
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
PNAS, May 25, 2004; 101(21): 8120 - 8125.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. McCracken, E. Gallery, and J. M. Morris
Pregnancy-Specific Down-Regulation of NF-{kappa}B Expression in T Cells in Humans Is Essential for the Maintenance of the Cytokine Profile Required for Pregnancy Success
J. Immunol., April 1, 2004; 172(7): 4583 - 4591.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, S. Shapira, N. Mason, K. M. Speirs, M. Goldschmidt, J. Caamano, H.-C. Liou, C. A. Hunter, and P. Scott
Differential Requirement for NF-{kappa}B Family Members in Control of Helminth Infection and Intestinal Inflammation
J. Immunol., October 15, 2002; 169(8): 4481 - 4487.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.